DFCM
KRYS icon

Dark Forest Capital Management’s Krystal Biotech KRYS Stock Holding History

Dark Forest Capital Management’s Portfolio KRYS Stock Details KRYS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-5,903
Closed -$1.04M – 1175
2025
Q3 		$1.04M Buy
5,903
+399
+7% +$59.7K 0.04% 724
2025
Q2 		$757K Sell
5,504
-3,933
-42% -$578K 0.03% 830
2025
Q1 		$1.7M Buy
+9,437
New +$1.59M 0.08% 446
2021
Q3 		– Sell
-318
Closed -$22K – 1412
2021
Q2 		$22K Buy
+318
New +$22.2K 0.01% 554

Other funds holding KRYS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
HRCM
Hood River Capital Management Palm Beach Gardens, Florida $9.98B AUM 145.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Dark Forest Capital Management's KRYS Position: Q4 2025 in Review

Dark Forest Capital Management sold out of Krystal Biotech (KRYS) in Q4 2025, closing a stake of 5,903 shares — an estimated $1.04M sold.

Dark Forest Capital Management first reported a position in KRYS in Q2 2021 and held it in 4 quarters. The position peaked at $1.7M in Q1 2025. 334 funds tracked by Wall St. Rank hold KRYS as of Q4 2025.

  • Dark Forest Capital Management reported no remaining Krystal Biotech position as of Q4 2025 after selling out during the quarter.
  • Dark Forest Capital Management sold 5,903 Krystal Biotech shares in Q4 2025, an estimated $1.04M.
  • Dark Forest Capital Management first reported a position in Krystal Biotech in Q2 2021 and held it in 4 quarters.
  • Dark Forest Capital Management's Krystal Biotech position peaked at $1.7M in Q1 2025.
  • 334 funds tracked by Wall St. Rank held Krystal Biotech as of Q4 2025.

Based on Dark Forest Capital Management's 13F filing for Q4 2025, filed 17 Feb 2026.